4 days agoTechnology | Special SituationsAduro Clean Technologies Corporate UpdateAduro pleased to provide shareholders with an update on some of the Company's most significant developments since the start of 2022.
May 11Health | BiotechnologyRakovina Presents Preclinical Data at the 2022 AACR Special Conference on SarcomasRakovina highlighted the development of its kt-3000 drug candidates as a potential treatment of Ewing sarcoma and other soft tissue tutors..
May 9ResourceNorden Completes High Resolution Ground Magnetic Survey at Fredrikssons Gruvan, Gumsberg ProjectThis is the largest and highest-resolution magnetic survey completed in the history of the area.
May 9Health | BiotechnologyResverlogix Announces Type C Meeting with FDA for Phase 3 High-risk COVID-19 Outpatient StudyFDA has granted the request for a meeting to review the clinical trial protocol for its Phase 3 study in high-risk COVID-19 outpatients.